Lupin and Tenpoint Therapeutics Announce Strategic Partnership to Commercialise YUVEZZI in Europe
Lupin and Tenpoint Therapeutics partner to commercialise YUVEZZI in the European Union (EU), The UK, Switzerland, Norway, and Iceland and expand access to the once-daily dual-agent eye drop for presbyopia.
Once-daily Presbyopia Eye Drop | 20/08/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy